Acute Pisa syndrome after administration of a single dose of mirtazapine [caso clínico]
Por: Llamas Velasco, Sara [Neurología]
| Méndez Guerrero, Antonio [Neurología ] | Murcia García, Francisco José [Neurología] | Ruiz Morales, Juan Manuel [Neurología].
Colaborador(es): Servicio de Neurología-Neurofisiología.
Editor: Clinical neuropharmacology, 2013Descripción: 36(4):133-4.Recursos en línea: Solicitar documento Resumen: Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Caso clínico
|
PC5233 (Navegar estantería) | Disponible |
Navegando Hospital Universitario 12 de Octubre Estantes Cerrar el navegador de estanterías
Formato Vancouver:
Méndez Guerrero A, Llamas S, Murcia FJ, Ruíz J. Acute Pisa syndrome after administration of a single dose of mirtazapine. Clin Neuropharmacol. 2013 Jul-Aug;36(4):133-4.
PMID: 23783006
Contiene 15 referencias
Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.
No hay comentarios para este ejemplar.